SCHEMBL12923940

SCHEMBL12923940

COc1ccc(CN(CC#CCO[C@H](CC#Cc2ccc(C)cc2C)c2ccccc2)CCC#N)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PBRM1 Q86U86 1/20 0.33
NR1H3 Q13133 2/20 0.33
KCNH2 Q12809 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PPARA Q07869 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
NOS2 P35228 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
NPC1 O15118 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL988222 0.95 CYP2D6 (0.35) ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL988223 0.95 CYP2D6 (0.35) ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL12923939 0.76 CYP3A4 (0.40) ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL987824 0.72 ALDH1A1 (0.44) ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL987821 0.72 ALDH1A1 (0.44) ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL988231 0.71 CYP2D6 (0.38) CYP2D6PBRM1KMT2AMEN1SLC6A2
SCHEMBL988229 0.71 CYP2D6 (0.38) CYP2D6PBRM1KMT2AMEN1SLC6A2
SCHEMBL12949375 0.69 CYP2D6 (0.38) ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL988232 0.68 ALDH1A1 (0.38) ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL988230 0.68 ALDH1A1 (0.38) ALDH1A1CYP2D6CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110003776-A1 TETRAHYDROPYRANONAPHTHYRIDINES DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC TREATMENT THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003776-A1 TETRAHYDROPYRANONAPHTHYRIDINES DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC TREATMENT THEREOF TPMT, TYMS, QDPR ALDH1A1 1282/4885CYP2D6 83/4885CYP1A2 292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.